Cancer Immunotherapy Drug Discovery Outsourcing Market Size, Share & Trends Analysis Report By Drug, By Service, By Cancer Type (Lung, Breast, Colorectal, Melanoma, Prostate, Pancreatic), By Region, And Segment Forecasts, 2022 - 2030

July 2022 | 98 pages | ID: CD1F0EF3CDEEN
Grand View Research, Inc.

Abstracts

This report can be delivered to the clients within 3 Business Days

Cancer Immunotherapy Drug Discovery Outsourcing Market Growth & Trends

The global cancer immunotherapy drug discovery outsourcing market size is expected to reach USD 2.6 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 10.2% from 2022 to 2030. The main drivers of this market are the increasing prevalence of cancer Worldwide, increasing investment by pharmaceutical and biotechnology companies in cancer research, and the rise in awareness among people for advanced treatment of cancer.

In the early stages of the COVID-19 pandemic, there was a halt in the growth of the cancer immunotherapy drug discovery market. This decrease in cancer immunotherapy drug discovery is due to the influx of a large number of patients that are infected with COVID-19 and require immediate intensive care and treatment. Also, disruptions in the supply chain, travel restrictions to prevent pandemics, and strict regulations have resulted in delays in the cancer immunotherapy drug discovery market. However, this impact will be significantly reduced by adopting strategic methods taken by pharmaceutical companies and regulatory authorities.

Other drivers of the market are the rising demand for outsourcing of drug discovery, which is increasing rapidly due to low cost as compared to in-house R & D costs, and the use of a tax credit that allows several benefits, like it reduces problems that are generally encountered with taxation authorities and it allows pharmaceutical and biotechnology companies to plan effectively their global projects with CRO. Also, government is actively participating and taking initiatives for cancer treatment. For instance, in April 2022, government launched 17 hospitals for treatment of cancer. This is a joint initiative taken by Tata trust and government, to create affordable cancer care network.

Also, there is the development of various new molecules for cancer immunotherapy and new immunotherapeutic options such as checkpoint inhibitors, immunomodulators, tumor-infiltrating lymphocytes, and CAR-T cell therapy. Several others are still in the pipeline to check their efficacy against cancer.

Cancer Immunotherapy Drug Discovery Outsourcing Market Report Highlights

• The monoclonal antibodies segment dominated the market and accounted for the largest revenue share of 64.3% in 2021. This growth is due to high efficacy and rise in regulatory approvals
• The lead screening and characterization segment is expected to account for the fastest CAGR of 10.5% during the forecast period. This is due to rise in new and effective ways to decrease time for effective assays in this segment
• The lung cancer segment accounted for the largest revenue share of 24.0% in 2021. This rise is due to large number of prevalent effective immunotherapies for this cancer type
• North America dominated the market and accounted for revenue share of 36.3% in 2021. This is due to a rise in demand for new technologies and an increasing incidence of cancer in the region

Contents

CHAPTER 1 METHODOLOGY AND SCOPE

1.1 Research Methodology
1.2 Research Scope and Assumptions

CHAPTER 2 EXECUTIVE SUMMARY

2.1 Market Summary

CHAPTER 3 MARKET VARIABLES, TRENDS & SCOPE

3.1 Market Segmentation
3.2 Market Variable Analysis
  3.2.1 Market Driver Analysis
    3.2.1.1 Increasing in-house R&D costs
    3.2.1.2 Increasing adoption of advanced technologies
    3.2.1.3 Mergers and acquisitions
    3.2.1.4 Tax credit
  3.2.2 Market Restraint Analysis
    3.2.2.1 Quality issues involved with drug discovery cro services
    3.2.2.2 Intellectual property right issues
3.3 Cancer Immunotherapy Drug Discovery Outsourcing: Market Analysis Tool
  3.3.1 Pestel Analysis
  3.3.2 Porter’s Five Forces Analysis
3.4 COVID- 19 Impact Analysis of Cancer Immunotherapy Drug Discovery Outsourcing Market

CHAPTER 4 DRUG TYPE BUSINESS ANALYSIS

4.1 Cancer Immunotherapy Drug Discovery Outsourcing Market: Drug Movement Analysis
4.2 Monoclonal Antibodies
  4.2.1 Monoclonal Antibodies market estimates and forecast, 2018 - 2030 (USD Million)
4.3 Immunomodulators
  4.3.1 Immunomodulators market estimates and forecast, 2018 - 2030 (USD Million)
4.4 Cancer Vaccines and Oncolytic Therapies
  4.4.1 Cancer Vaccines and Oncolytic Therapies market estimates and forecast, 2018 - 2030 (USD Million)
4.5 Others
  4.5.1 Others market estimates and forecast, 2018 - 2030 (USD Million)

CHAPTER 5 SERVICE BUSINESS ANALYSIS

5.1 Cancer Immunotherapy Drug Discovery Outsourcing Market: Service Movement Analysis
5.2 Target Identification and Validation
  5.2.1 Target Identification and Validation market estimates and forecast, 2018 - 2030 (USD Million)
5.3 Lead screening and Characterization
  5.3.1 Lead screening and characterization market estimates and forecast, 2018 - 2030 (USD Million)
5.4 Cell based Assays
  5.4.1 Cell Based Assays market estimates and forecast, 2018 - 2030 (USD Million)

CHAPTER 6 CANCER TYPE BUSINESS ANALYSIS

6.1 Cancer Immunotherapy Drug Discovery Outsourcing Market: Cancer Type Movement Analysis
6.2 Lung Cancer
  6.2.1 Lung Cancer market estimates and forecast, 2018 - 2030 (USD Million)
6.3 Breast Cancer
  6.3.1 Breast Cancer market estimates and forecast, 2018 - 2030 (USD Million)
6.4 Colorectal Cancer
  6.4.1 Colorectal cancer market estimates and forecast, 2018 - 2030 (USD Million)
6.5 Melanoma
  6.5.1 Melanoma market estimates and forecast, 2018 - 2030 (USD Million)
6.6 Prostate Cancer
  6.6.1 Prostate cancer market estimates and forecast, 2018 - 2030 (USD Million)
6.7 Head and Neck Cancer
  6.7.1 Head and Neck cancer market estimates and forecast, 2018 - 2030 (USD Million)
6.8 Ovarian Cancer
  6.8.1 Ovarian cancer market estimates and forecast, 2018 - 2030 (USD Million)
6.9 Pancreatic Cancer
  6.9.1 Pancreatic cancer market estimates and forecast, 2018 - 2030 (USD Million)

CHAPTER 7 REGIONAL BUSINESS ANALYSIS

7.1 Cancer Immunotherapy Drug Discovery Outsourcing Market: Regional Movement Analysis
7.2 North America.
  7.2.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
  7.2.2 U.S.
    7.2.2.1 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  7.2.3 Canada
    7.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.3 Europe
  7.3.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
  7.3.2 Germany
    7.3.2.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
  7.3.3 U.K.
    7.3.3.1 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.4 Asia Pacific
  7.4.1 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  7.4.2 india
    7.4.2.1 India market estimates and forecast, 2018 - 2030 (USD Million)
  7.4.3 China.
    7.4.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.5 Latin-America
  7.5.1 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
  7.5.2 Brazil
    7.5.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
  7.5.3 Mexico
    7.5.3.1 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.6 Middle East & Africa
  7.6.1 Middle East and Africa market estimates and forecast, 2018 - 2030 (USD Million)
  7.6.2 South Africa
    7.6.2.1 South Africa market estimates and forecast, 2018 - 2030 (USD Million)

CHAPTER 8 COMPANY PROFILE

8.1 Strategy Framework
8.2 Explicyte Immuno-Oncology
  8.2.1 Company Overview
  8.2.2 Swot Analysis
  8.2.3 Product Benchmarking
  8.2.4 Strategic Initiatives
8.3 Aquila Biomedical
  8.3.1 Company Overview
  8.3.2 Swot Analysis
  8.3.3 Product Benchmarking
  8.3.4 Strategic Initiatives
8.4 Horizon Discovery Group plc
  8.4.1 Company Overview
  8.4.2 Swot Analysis
  8.4.3 Financial Performance
  8.4.4 Product Benchmarking
  8.4.5 Strategic Initiatives
8.5 Crown Bioscience Inc.
  8.5.1 Company Overview
  8.5.2 Swot Analysis
  8.5.3 Financial Performance
  8.5.4 Product Benchmarking
  8.5.5 Strategic Initiatives
8.6 Promega Corporation
  8.6.1 Company Overview
  8.6.2 Swot Analysis
  8.6.3 Product Benchmarking
  8.6.4 Strategic Initiatives
8.7 HD Co. Ltd.
  8.7.1 Company Overview
  8.7.2 Swot Analysis
  8.7.3 Product Benchmarking
  8.7.4 Strategic Biosciences Initiatives
8.8 BPS Biosciences Inc.
  8.8.1 Company Overview
  8.8.2 Swot Analysis
  8.8.3 Product Benchmarking
  8.8.4 Strategic Initiatives
8.9 Gen script Biotech Corporation
  8.9.1 Company Overview
  8.9.2 Swot Analysis
  8.9.3 Financial Performance
  8.9.4 Product Benchmarking
  8.9.5 Strategic Initiatives
8.10 Celentyx Ltd.
  8.10.1 Company Overview
  8.10.2 Swot Analysis
  8.10.3 Product Benchmarking
  8.10.4 Strategic Initiatives
8.11 ImmuneXperts SA
  8.11.1 Company Overview
  8.11.2 Swot Analysis
  8.11.3 Product Benchmarking
  8.11.4 Strategic Initiatives
8.12 Personalis
  8.12.1 Company Overview
  8.12.2 Swot Analysis
  8.12.3 Product Benchmarking
  8.12.4 Strategic Initiatives
8.13 STC Biologics
  8.13.1 Company Overview
  8.13.2 Swot Analysis
  8.13.3 Product Benchmarking
  8.13.4 Strategic Initiatives
8.14 Molecular Imaging Inc. (MI Bioresearch Inc.)
  8.14.1 Company Overview
  8.14.2 Swot Analysis
  8.14.3 Product Benchmarking
  8.14.4 Strategic Initiatives
8.15 Covance, Inc.
  8.15.1 Company Overview
  8.15.2 Swot Analysis
  8.15.3 Financial Performance
  8.15.4 Product Benchmarking
  8.16.5 Strategic Initiatives

List Of Tables

LIST OF TABLES

Table 1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Region (USD Million)
Table 2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Drug Type (USD Million)
Table 3 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Service Type (USD Million)
Table 4 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cancer Type (USD Million)
Table 5 North America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Country (USD Million)
Table 6 North America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Drug Type (USD Million)
Table 7 North America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Service Type (USD Million)
Table 8 North America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cancer Type (USD Million)
Table 9 U.S. Cancer Immunotherapy Drug Discovery Outsourcing Market, By Drug Type (USD Million)
Table 10 U.S. Cancer Immunotherapy Drug Discovery Outsourcing Market, By Service Type (USD Million)
Table 11 U.S. Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cancer Type (USD Million)
Table 12 Canada Cancer Immunotherapy Drug Discovery Outsourcing Market, By Drug Type (USD Million)
Table 13 Canada Cancer Immunotherapy Drug Discovery Outsourcing Market, By Service Type (USD Million)
Table 14 Canada Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cancer Type (USD Million)
Table 15 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, By Country (USD Million)
Table 16 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, By Drug Type (USD Million)
Table 17 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, By Service Type (USD Million)
Table 18 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cancer Type (USD Million)
Table 19 U.K. Cancer Immunotherapy Drug Discovery Outsourcing Market, By Drug Type (USD Million)
Table 20 U.K. Cancer Immunotherapy Drug Discovery Outsourcing Market, By Service Type (USD Million)
Table 21 U.K. Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cancer Type (USD Million)
Table 22 Germany Cancer Immunotherapy Drug Discovery Outsourcing Market, By Drug Type (USD Million)
Table 23 Germany Cancer Immunotherapy Drug Discovery Outsourcing Market, By Service Type (USD Million)
Table 24 Germany Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cancer Type (USD Million)
Table 25 Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, By Region (USD Million)
Table 26 Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, By Drug Type (USD Million)
Table 27 Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, By Service Type (USD Million)
Table 28 Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cancer Type (USD Million)
Table 29 China Cancer Immunotherapy Drug Discovery Outsourcing Market, By Drug Type (USD Million)
Table 30 China Cancer Immunotherapy Drug Discovery Outsourcing Market, By Service Type (USD Million)
Table 31 China Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cancer Type (USD Million)
Table 32 India Cancer Immunotherapy Drug Discovery Outsourcing Market, By Drug Type (USD Million)
Table 33 India Cancer Immunotherapy Drug Discovery Outsourcing Market, By Service Type (USD Million)
Table 34 India Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cancer Type (USD Million)
Table 35 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Region (USD Million)
Table 36 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Drug Type (USD Million)
Table 37 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Service Type (USD Million)
Table 38 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cancer Type (USD Million)
Table 39 Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market, By Drug Type (USD Million)
Table 40 Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market, By Service Type (USD Million)
Table 41 Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cancer Type (USD Million)
Table 42 Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market, By Drug Type (USD Million)
Table 43 Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market, By Service Type (USD Million)
Table 44 Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cancer Type (USD Million)
Table 45 MEA Cancer Immunotherapy Drug Discovery Outsourcing Market, By Region Type (USD Million)
Table 46 MEA Cancer Immunotherapy Drug Discovery Outsourcing Market, By Drug Type (USD Million)
Table 47 MEA Cancer Immunotherapy Drug Discovery Outsourcing Market, By Service Type (USD Million)
Table 48 MEA Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cancer Type (USD Million)
Table 49 South Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By Drug Type (USD Million)
Table 50 South Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By Service Type (USD Million)
Table 51 South Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cancer Type (USD Million)

List Of Figures

LIST OF FIGURES

Fig. 1 Cancer immunotherapy drug discovery outsourcing market snapshot
Fig. 2 Cancer immunotherapy drug discovery outsourcing market segmentation
Fig. 3 Cancer immunotherapy drug discovery outsourcing market driver impact
Fig. 4 Cancer immunotherapy drug discovery outsourcing market restraint impact
Fig. 5 SWOT analysis, By Factor (political & legal economic and technological)
Fig. 6 Porter’s five forces analysis
Fig. 7 Cancer immunotherapy drug discovery outsourcing market: Drug type outlook and key takeaways
Fig. 8 Cancer immunotherapy drug discovery outsourcing market: Drug movement analysis
Fig. 9 Monoclonal antibodies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 10 Immunomodulators market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 11 Cancer vaccines and oncolytic therapies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 12 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 13 Cancer immunotherapy drug discovery outsourcing market: Service outlook and key takeaways
Fig. 14 Cancer immunotherapy drug discovery outsourcing market: Service movement analysis
Fig. 15 Target identification and validation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 16 Lead screening and characterization market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 17 Cell-based assays market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 Cancer immunotherapy drug discovery outsourcing market: Cancer outlook and key takeaways
Fig. 19 Cancer immunotherapy drug discovery outsourcing market: Service movement analysis
Fig. 20 Lung cancer market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Breast cancer market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Colorectal cancer market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Melanoma market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Prostate cancer market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Head and neck cancer market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Ovarian cancer market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Pancreatic cancer market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Cancer immunotherapy drug discovery outsourcing market: regional outlook and key takeaways
Fig. 29 Cancer immunotherapy drug discovery outsourcing market: Regional movement analysis
Fig. 30 North America
Fig. 31 North America market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Canada market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Europe
Fig. 35 Europe market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Germany market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Asia Pacific
Fig. 39 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 India market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 China market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Latin America
Fig. 43 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Middle East & Africa
Fig. 47 Middle East and Africa market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 49 Strategy Framework